No black box warning on record for Fosinopril Sodium

As of the latest FDA labeling reviewed, Fosinopril Sodium (FOSINOPIRL SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fosinopril Sodium medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including fosinopril sodium) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema involving the extremities,

No black box warning on record for Fosinopril Sodium

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including fosinopril sodium) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema involving the extremities,

Fosinopril Sodium Black Box Warning

No black box warning on record for Fosinopril Sodium

Other warnings & precautions

Fosinopril Sodium Black Box Warning

No black box warning on record for Fosinopril Sodium

Other warnings & precautions